Edwards Training Village at EACTS 2025
Edwards Training Village: RESILIA technology
This session offers an overview of RESILIA tissue technology and its clinical applications. Participants will explore key features, durability data, and surgical considerations through interactive discussions and practical demonstrations.
Thursday 9 Oct 2025
RESILIA Tissue Technology
Friday 10 Oct 2025
RESILIA Tissue Technology
Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.
Reference: Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).